SII seeks DCGI nod for phase-3 trial of Covovax as booster dose
Pune-based vaccine manufacturer Serum Institute of India (SII) has sought permission from Drugs Controller General Of India (DCGI) to conduct phase-3 study of Covovax vaccine as booster dose